316 related articles for article (PubMed ID: 16440205)
21. Role of exogenous surfactant in acute lung injury.
Lewis JF; Brackenbury A
Crit Care Med; 2003 Apr; 31(4 Suppl):S324-8. PubMed ID: 12682460
[TBL] [Abstract][Full Text] [Related]
22. Animal models and clinical pilot studies of surfactant replacement in adult respiratory distress syndrome.
Lachmann B
Eur Respir J Suppl; 1989 Mar; 3():98s-103s. PubMed ID: 2663002
[TBL] [Abstract][Full Text] [Related]
23. Advances with surfactant.
Turell DC
Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
[TBL] [Abstract][Full Text] [Related]
24. Is surfactant a promising additive drug in ALI/ARDS-patients?
Schultz MJ; Kesecioglu J
Curr Drug Targets; 2004 Jul; 5(5):445-8. PubMed ID: 15216910
[TBL] [Abstract][Full Text] [Related]
25. Surfactant therapy for acute lung injury and acute respiratory distress syndrome.
Raghavendran K; Willson D; Notter RH
Crit Care Clin; 2011 Jul; 27(3):525-59. PubMed ID: 21742216
[TBL] [Abstract][Full Text] [Related]
26. Surfactant therapy in adults with acute lung injury/acute respiratory distress syndrome.
Kesecioglu J; Haitsma JJ
Curr Opin Crit Care; 2006 Feb; 12(1):55-60. PubMed ID: 16394785
[TBL] [Abstract][Full Text] [Related]
27. [Surfactant-BL and inhaled nitric oxide in acute respiratory distress syndrome in cardiac surgical patients].
Kozlov IA; Poptsov VN
Anesteziol Reanimatol; 2005; (6):38-41. PubMed ID: 16499105
[TBL] [Abstract][Full Text] [Related]
28. Surfactant supplementation in the lung.
Anzueto A
Respir Care Clin N Am; 2002 Jun; 8(2):211-36. PubMed ID: 12481816
[TBL] [Abstract][Full Text] [Related]
29. Role of pulmonary surfactant in the development and treatment of adult respiratory distress syndrome.
Holm BA; Matalon S
Anesth Analg; 1989 Dec; 69(6):805-18. PubMed ID: 2686493
[TBL] [Abstract][Full Text] [Related]
30. [Preterm and term infants with acute respiratory distress syndrome (ARDS): what is the role of surfactant substitution?].
Wirbelauer J; Thomas W; Speer CP
Z Geburtshilfe Neonatol; 2009 Apr; 213(2):33-41. PubMed ID: 19319791
[TBL] [Abstract][Full Text] [Related]
31. Three-dimensional model of surfactant replacement therapy.
Filoche M; Tai CF; Grotberg JB
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9287-92. PubMed ID: 26170310
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary surfactant subfractions in patients with the acute respiratory distress syndrome.
Veldhuizen RA; McCaig LA; Akino T; Lewis JF
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1867-71. PubMed ID: 8520748
[TBL] [Abstract][Full Text] [Related]
33. Perspectives for use of surfactant in children and adults.
Marraro GA
J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():29-31. PubMed ID: 15590431
[TBL] [Abstract][Full Text] [Related]
34. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.
Seeger W; Günther A; Walmrath HD; Grimminger F; Lasch HG
Clin Investig; 1993 Mar; 71(3):177-90. PubMed ID: 8481620
[TBL] [Abstract][Full Text] [Related]
35. Role of surfactant in the pathophysiology of the acute respiratory distress syndrome (ARDS).
Hartog A; Gommers D; Lachmann B
Monaldi Arch Chest Dis; 1995 Oct; 50(5):372-7. PubMed ID: 8541821
[TBL] [Abstract][Full Text] [Related]
36. Surfactant therapy for acute lung injury/acute respiratory distress syndrome.
Haitsma JJ; Papadakos PJ; Lachmann B
Curr Opin Crit Care; 2004 Feb; 10(1):18-22. PubMed ID: 15166845
[TBL] [Abstract][Full Text] [Related]
37. Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome.
Spragg RG; Lewis JF; Walmrath HD; Johannigman J; Bellingan G; Laterre PF; Witte MC; Richards GA; Rippin G; Rathgeb F; Häfner D; Taut FJ; Seeger W
N Engl J Med; 2004 Aug; 351(9):884-92. PubMed ID: 15329426
[TBL] [Abstract][Full Text] [Related]
38. Surfactant and the adult respiratory distress syndrome.
Lewis JF; Jobe AH
Am Rev Respir Dis; 1993 Jan; 147(1):218-33. PubMed ID: 8420422
[TBL] [Abstract][Full Text] [Related]
39. Adult respiratory distress syndrome and artificial surfactant replacement in the pediatric patient.
Perez-Benavides F; Riff E; Franks C
Pediatr Emerg Care; 1995 Jun; 11(3):153-5. PubMed ID: 7651868
[TBL] [Abstract][Full Text] [Related]
40. Respiratory and Systemic Effects of LASSBio596 Plus Surfactant in Experimental Acute Respiratory Distress Syndrome.
Silva JD; de Oliveira GP; Samary Cdos S; Araujo CC; Padilha Gde A; Costa e Silva Filho F; da Silva RT; Einicker-Lamas M; Morales MM; Capelozzi VL; da Silva VM; Lima LM; Barreiro EJ; Diaz BL; Pelosi P; Silva PL; Garcia CS; Rocco PR
Cell Physiol Biochem; 2016; 38(2):821-35. PubMed ID: 26905925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
